Rite Aid Corp.

RAD-N

NYSE:RAD

8.29
0.25 (3.11%)
Rite Aid Corporation is a drugstore chain in the United States and a Fortune 500 company. It is headquartered in East Pennsboro Township, Cumberland County, Pennsylvania, near Camp Hill.
More at Wikipedia

Analysis and Opinions about RAD-N

Signal
Opinion
Expert
HOLD
HOLD
October 22, 2018

It has been one of his biggest losers. At this point it is an iffy company. He is holding it because he thinks there is some upside. They could get taken out still.

Rite Aid Corp. (RAD-N)
October 22, 2018

It has been one of his biggest losers. At this point it is an iffy company. He is holding it because he thinks there is some upside. They could get taken out still.

Benj Gallander
President, Contra the Heard Investment Letter
Price
$1.030
Owned
Yes
COMMENT
COMMENT
November 24, 2017

Getting a $5 billion injection from Walgreen which will help with their long-term debt. Has had his brains blown out of the water on this stock. Bought it as an arbitrage play because of Walgreen. Has bought more recently. This has been one of his big losers. He is happy to hold it as he thinks it has a lot of upside. Same-store sales going down in a company is not great.

Rite Aid Corp. (RAD-N)
November 24, 2017

Getting a $5 billion injection from Walgreen which will help with their long-term debt. Has had his brains blown out of the water on this stock. Bought it as an arbitrage play because of Walgreen. Has bought more recently. This has been one of his big losers. He is happy to hold it as he thinks it has a lot of upside. Same-store sales going down in a company is not great.

Benj Gallander
President, Contra the Heard Investment Letter
Price
$1.640
Owned
Yes
DON'T BUY
DON'T BUY
September 19, 2017

The deal to be acquired by Walgreens (WBA-Q) didn’t get off the ground. There were some antitrust issues. However, they struck a deal to buy individual stores. It is going to take Walgreens from about 8000 stores to about 10,000, which will compete pretty much head-to-head with CVS (CVS-N). These stores are not as efficient and need some work. Also the company needs some capital, because they need to improve their offering.

Rite Aid Corp. (RAD-N)
September 19, 2017

The deal to be acquired by Walgreens (WBA-Q) didn’t get off the ground. There were some antitrust issues. However, they struck a deal to buy individual stores. It is going to take Walgreens from about 8000 stores to about 10,000, which will compete pretty much head-to-head with CVS (CVS-N). These stores are not as efficient and need some work. Also the company needs some capital, because they need to improve their offering.

Gordon Reid
President, GoodReid Investment Counsel
Price
$2.400
Owned
No
HOLD
HOLD
August 3, 2017

Doesn’t think there is really an issue with this stock. Pharmacies haven’t quite been where the action is in the healthcare vertical. This is a decent name.

Rite Aid Corp. (RAD-N)
August 3, 2017

Doesn’t think there is really an issue with this stock. Pharmacies haven’t quite been where the action is in the healthcare vertical. This is a decent name.

John Stephenson
President & CEO, Stephenson & Company Capital Management
Price
$2.390
Owned
Unknown
PAST TOP PICK
PAST TOP PICK
January 25, 2017

(A Top Pick Oct 11/16. Down 3.59%.) This was and is subject to a takeover offer by Walgreens. Sold his holdings at about $8.30.

Rite Aid Corp. (RAD-N)
January 25, 2017

(A Top Pick Oct 11/16. Down 3.59%.) This was and is subject to a takeover offer by Walgreens. Sold his holdings at about $8.30.

Dean Orrico
President, Middlefield Capital Corp.
Price
$6.900
Owned
No
TOP PICK
TOP PICK
October 11, 2016

About a year ago, Walgreen Boots Alliance (WBA-Q) wanted to take this over in a friendly deal, at $9. For the better part of 9 months, the stock didn’t move. There have been a number of M&A transactions in the healthcare space that didn’t work out, so all the risk arbitrage players who were focused on healthcare weren’t playing it. He is sure this is a transaction that is going to happen, which would give you a 20% lift.

Rite Aid Corp. (RAD-N)
October 11, 2016

About a year ago, Walgreen Boots Alliance (WBA-Q) wanted to take this over in a friendly deal, at $9. For the better part of 9 months, the stock didn’t move. There have been a number of M&A transactions in the healthcare space that didn’t work out, so all the risk arbitrage players who were focused on healthcare weren’t playing it. He is sure this is a transaction that is going to happen, which would give you a 20% lift.

Dean Orrico
President, Middlefield Capital Corp.
Price
$7.370
Owned
Yes
COMMENT
COMMENT
June 22, 2016

He doesn’t cover this, because as a pharmacy it is considered a consumer staple. Right now this is being subject to a takeover by Walgreen Boots Alliance (WBA-Q).

He doesn’t cover this, because as a pharmacy it is considered a consumer staple. Right now this is being subject to a takeover by Walgreen Boots Alliance (WBA-Q).

Paul MacDonald
Chief Investment Officer & Portfolio Manager, Harvest Portfolios Group
Price
$7.730
Owned
No
COMMENT
COMMENT
March 2, 2016

This has been the “sick man” of the pharmacy business. It is now dominated by CVS and the Walgreen conglomerate, and there would be serious anti-trust concerns if one of those 2 bought this company. A great sector to be in.

This has been the “sick man” of the pharmacy business. It is now dominated by CVS and the Walgreen conglomerate, and there would be serious anti-trust concerns if one of those 2 bought this company. A great sector to be in.

David Baskin
President, Baskin Wealth Management
Price
$7.970
Owned
Unknown
DON'T BUY
DON'T BUY
December 15, 2015

Pharmacy stocks are defensive holdings overall. The best time from a seasonal perspective, is really when everybody else is perturbed by the market, which is in the summer months. He wouldn’t be investing in this right now. Chart shows this is still in a downward trend.

Rite Aid Corp. (RAD-N)
December 15, 2015

Pharmacy stocks are defensive holdings overall. The best time from a seasonal perspective, is really when everybody else is perturbed by the market, which is in the summer months. He wouldn’t be investing in this right now. Chart shows this is still in a downward trend.

Brooke Thackray
Research Analyst, Horizons ETFs (Canada) Inc.
Price
$7.800
Owned
No
DON'T BUY
DON'T BUY
September 22, 2015

The type of company that tends to hold in pretty well in weak markets. Weak markets are where you can get good companies that haven’t held in well and don’t seem all that safe. There are other places that he would go to, but in a different sector.

Rite Aid Corp. (RAD-N)
September 22, 2015

The type of company that tends to hold in pretty well in weak markets. Weak markets are where you can get good companies that haven’t held in well and don’t seem all that safe. There are other places that he would go to, but in a different sector.

Bruce Tatters
Founding Partner and CIO, Triumph Asset Management
Price
$7.170
Owned
No
DON'T BUY
DON'T BUY
September 17, 2015

Just announced that some of their earnings are going to be rough going forward. He prefers CVS Health (CVS-N). Rite Aid has been beaten up quite a bit.

Rite Aid Corp. (RAD-N)
September 17, 2015

Just announced that some of their earnings are going to be rough going forward. He prefers CVS Health (CVS-N). Rite Aid has been beaten up quite a bit.

Stan Wong
Director & Portfolio Manager, Private Wealth Management, ScotiaMcleod
Price
$7.660
Owned
No
DON'T BUY
DON'T BUY
August 28, 2015

Thinks the turnaround has been completed. They are now profitable again, not hugely so, but thinks they have turned the corner. The stock has rebounded dramatically from its lows. This is the 3rd biggest player in its group and he doesn’t see how you would want to pay 25X earnings for this, compared to 17 to 20 times earnings for CVS (CVS-N) or Walgreen’s (WBA-Q), which have a lot more going for them. Good sector.

Rite Aid Corp. (RAD-N)
August 28, 2015

Thinks the turnaround has been completed. They are now profitable again, not hugely so, but thinks they have turned the corner. The stock has rebounded dramatically from its lows. This is the 3rd biggest player in its group and he doesn’t see how you would want to pay 25X earnings for this, compared to 17 to 20 times earnings for CVS (CVS-N) or Walgreen’s (WBA-Q), which have a lot more going for them. Good sector.

Don Lato
President, Padlock Investment Management
Price
$8.240
Owned
Unknown
HOLD
HOLD
October 8, 2014

Looked at this when it was around $2. Didn’t like the salaries of managers. Had a big debt load. This is still on his Watch List and he is watching for further weakness in the sector. A good sector to be in because drug companies are tremendous at marketing people.

Rite Aid Corp. (RAD-N)
October 8, 2014

Looked at this when it was around $2. Didn’t like the salaries of managers. Had a big debt load. This is still on his Watch List and he is watching for further weakness in the sector. A good sector to be in because drug companies are tremendous at marketing people.

Benj Gallander
President, Contra the Heard Investment Letter
Price
$5.010
Owned
No
DON'T BUY
DON'T BUY
September 30, 2014

Has Walgreen and CVS. This is the poor cousin. They had a tough with input costs and the stock was hurt badly. It will probably recover, but when you can buy the other two, just go with them. This one is more speculative.

Rite Aid Corp. (RAD-N)
September 30, 2014

Has Walgreen and CVS. This is the poor cousin. They had a tough with input costs and the stock was hurt badly. It will probably recover, but when you can buy the other two, just go with them. This one is more speculative.

Gordon Reid
President, GoodReid Investment Counsel
Price
$4.840
Owned
No
COMMENT
COMMENT
March 17, 2014

The poor relative to Walgreen (WAG-N). Has done really well in the last year or so but that is from a flirtation with bankruptcy. It is remarkable how some of the major retail chains in the US are in a very difficult, long-term position with the growth of ordering over the Internet. He would prefer to be with the leader Walgreen rather than being in the number 2 position.

Rite Aid Corp. (RAD-N)
March 17, 2014

The poor relative to Walgreen (WAG-N). Has done really well in the last year or so but that is from a flirtation with bankruptcy. It is remarkable how some of the major retail chains in the US are in a very difficult, long-term position with the growth of ordering over the Internet. He would prefer to be with the leader Walgreen rather than being in the number 2 position.

Gavin Graham
Trustee, Pointbreak ETFs
Price
$6.870
Owned
Unknown
DON'T BUY
DON'T BUY
April 27, 2009
This is not the right time to be a credit-constrained company. Good competition.
Rite Aid Corp. (RAD-N)
April 27, 2009
This is not the right time to be a credit-constrained company. Good competition.
Gavin Graham
Trustee, Pointbreak ETFs
Price
$0.950
Owned
Unknown
DON'T BUY
DON'T BUY
September 10, 2008
(Market Call Minute.) The most levered of the drugstores. Would go to Walgreen (WAG-N) instead.
Rite Aid Corp. (RAD-N)
September 10, 2008
(Market Call Minute.) The most levered of the drugstores. Would go to Walgreen (WAG-N) instead.
Pat Naccarato
Vice President and Portfolio Manager, AIC Limited
Price
$1.000
Owned
Unknown
DON'T BUY
DON'T BUY
July 20, 2007
Likes where management is going. This is a risk/reward situation and a turnaround story. Trades at a reasonable price/sales ratio, but has a lot of debt on the balance sheet. Made a large acquisition, which was too large for his liking.
Likes where management is going. This is a risk/reward situation and a turnaround story. Trades at a reasonable price/sales ratio, but has a lot of debt on the balance sheet. Made a large acquisition, which was too large for his liking.
Mike Lyons CA, CFA
Chief Investment Officer, Lyons Asset Management
Price
$5.910
Owned
No
DON'T BUY
DON'T BUY
July 17, 2007
Has a lot of debt. There is a lot of execution that has to happen.
Has a lot of debt. There is a lot of execution that has to happen.
Pat Naccarato
Vice President and Portfolio Manager, AIC Limited
Price
$6.120
Owned
Unknown
DON'T BUY
DON'T BUY
April 26, 2007
Very cheap compared to its competitors Walgreen (WAG-N) and CVS (CVS-N). Has a lot of value attributes. Have just merged and if this goes through well and they are able to execute, upside is very positive. Have taken on a lot of debt which concerns him.
Rite Aid Corp. (RAD-N)
April 26, 2007
Very cheap compared to its competitors Walgreen (WAG-N) and CVS (CVS-N). Has a lot of value attributes. Have just merged and if this goes through well and they are able to execute, upside is very positive. Have taken on a lot of debt which concerns him.
Pat Naccarato
Vice President and Portfolio Manager, AIC Limited
Price
$6.310
Owned
No
HOLD
HOLD
April 23, 2007
Acquiring Brooks and Eckerd drugstore chains from Jean Coutu (PJC-T). They have enough scale, size and management to run these stores.
Rite Aid Corp. (RAD-N)
April 23, 2007
Acquiring Brooks and Eckerd drugstore chains from Jean Coutu (PJC-T). They have enough scale, size and management to run these stores.
Gavin Graham
Trustee, Pointbreak ETFs
Price
$6.390
Owned
Unknown
BUY
BUY
April 17, 2007
Hit a high in 03 and it is flirting with this old high now. During the last little move, there was a dramatic increase in volume. That's a sign there is real buying there. Put your stop at the recent low.
Rite Aid Corp. (RAD-N)
April 17, 2007
Hit a high in 03 and it is flirting with this old high now. During the last little move, there was a dramatic increase in volume. That's a sign there is real buying there. Put your stop at the recent low.
Kenneth P. Norquay, CMT
Partner, Castlemoore Inc.
Price
$6.460
Owned
Unknown
SELL
SELL
May 8, 2006
Hates this company. Has the worst balance sheet of any of the pharmacy retailers in the US. They have a lot of competitive disadvantages.
Hates this company. Has the worst balance sheet of any of the pharmacy retailers in the US. They have a lot of competitive disadvantages.
David Driscoll
President & CEO, Liberty International Investment Management Inc
Price
$4.670
Owned
No
DON'T BUY
DON'T BUY
March 30, 2006
Have reached a 2% same store sales growth. $3 billion of debt. The trouble with the whole area is that there is a lot of competition from the Wal-Mart's of the world getting into pharmacy, etc. Would prefer Walgreens.
Rite Aid Corp. (RAD-N)
March 30, 2006
Have reached a 2% same store sales growth. $3 billion of debt. The trouble with the whole area is that there is a lot of competition from the Wal-Mart's of the world getting into pharmacy, etc. Would prefer Walgreens.
Paul Harris, CFA
Partner and Portfolio Manager, Harris Douglas Asset Management
Price
$3.980
Owned
No
DON'T BUY
DON'T BUY
February 11, 2002
A lot of debt. Questionable management.
Rite Aid Corp. (RAD-N)
February 11, 2002
A lot of debt. Questionable management.
Paul O'Neil
Portfolio Manager, U.S. Equities, KBSH Capital Mngmnt
Price
$2.580
Owned
Unknown
Showing 1 to 25 of 25 entries
  • «
  • 1
  • »